Articles
Page 1 of 45
-
Citation: BMC Endocrine Disorders 2025 25:133
-
Predictive value of growth hormone and insulin-like growth factor-1 axis for gestational diabetes mellitus: a prospective cohort study
This study aimed to explore the role of growth hormone/insulin-like growth factor-1 risk factor axis in gestational diabetes mellitus, as well as to rank independently risk factors.
Citation: BMC Endocrine Disorders 2025 25:132 -
Expression and clinical significance of LncRNA Kcnq1ot1 in type 2 diabetes mellitus patients with osteoarthritis
We aimed to investigate the expression of lncRNA Kcnq1ot1 in T2DM patients with OA, as well as its correlation with serum inflammatory factors and clinical outcomes of the patients.
Citation: BMC Endocrine Disorders 2025 25:131 -
Effect of intermittent fasting on obesity and metabolic indices in patients with metabolic syndrome: a systematic review and meta analysis
Dietary patterns play a vital role in the health management of individuals with metabolic syndrome. Many recent studies have shown that intermittent fasting (IF) has better effects, such as improving obesity. ...
Citation: BMC Endocrine Disorders 2025 25:130 -
Explainable predictive models of short stature and exploration of related environmental growth factors: a case-control study
Short stature is a prevalent pediatric endocrine disorder for which early detection and prediction are pivotal for improving treatment outcomes. However, existing diagnostic criteria often lack the necessary s...
Citation: BMC Endocrine Disorders 2025 25:129 -
Unusual nodular goiter with recurrent laryngeal nerve palsy due to severe degeneration caused by intense chronic inflammation: a case report with histopathological evidence and review of the literature
Thyroid tumors presenting with recurrent laryngeal nerve (RLN) palsy are generally considered malignant; however, RLN palsy has been reported even in benign thyroid disease (BTD), mainly due to compression or ...
Citation: BMC Endocrine Disorders 2025 25:128 -
Retraction Note: PIWIL2 restrains the progression of thyroid cancer via interaction with miR-146a-3p
Citation: BMC Endocrine Disorders 2025 25:127 -
Application of the C-reactive protein-triglyceride glucose index in predicting the risk of new-onset diabetes in the general population aged 45 years and older: a national prospective cohort study
Triglyceride-to-glucose index (TyG index) and inflammation are both independent risk factors for diabetes. However, only a few studies have combined TyG index with inflammation indices to predict diabetes risk...
Citation: BMC Endocrine Disorders 2025 25:126 -
Association of CDKAL1 gene polymorphisms variations with gestational diabetes mellitus risk in women: A case-control study and meta-analysis
Gestational diabetes mellitus (GDM) has seen a significant rise and has become a growing concern worldwide, especially in Asian populations. Genetic factors, such as variations in the CDKAL1 gene, have been li...
Citation: BMC Endocrine Disorders 2025 25:125 -
Influence of glucagon-like peptide-1 receptor agonists on renal parameters: a meta-analysis of randomized controlled trials
To verify the influence of glucagon-like peptide-1 receptor agonists (GLP-1 RA) on renal function parameters in type 2 diabetes based on well-known randomized controlled trials (RCTs).
Citation: BMC Endocrine Disorders 2025 25:124 -
Insular thyroid carcinoma: epidemiological pattern, factors contributing to recurrence and distant metastasis
Insular thyroid carcinoma is a rare subtype of thyroid cancer that constitutes an intermediate entity between differentiated (papillary & follicular) and undifferentiated (anaplastic) thyroid cancer.
Citation: BMC Endocrine Disorders 2025 25:123 -
Prevalence of diabetes mellitus among traumatic patients admitted to Aseer Central Hospital, Aseer Region, Abha, Saudi Arabia: cross-sectional study
Traumatic injuries among patients with diabetes mellitus (DM) are associated with extended hospital stays and higher mortality rates.
Citation: BMC Endocrine Disorders 2025 25:122 -
Neonatal graves’ disease complicated with cholestatic jaundice: a case report
Neonatal cholestatic jaundice and elevated liver enzymes can result from various etiologies, including anatomical, infectious, endocrine, and metabolic abnormalities. Unlike hypothyroidism, hyperthyroidism is ...
Citation: BMC Endocrine Disorders 2025 25:121 -
Neutrophil-lymphocyte ratio (NLR); an accurate inflammatory marker to predict diabetic foot ulcer amputation: a matched case-control study
Diabetic foot ulcer (DFU) is a well-known complication of diabetes. The main therapeutic options for treating DFU include surgical debridement. However, conditions such as sensory loss and insufficient blood s...
Citation: BMC Endocrine Disorders 2025 25:120 -
The diagnostic role of FNA based on clinicopathological features in thyroid malignancy
Thyroid nodules are mostly benign lesions within the thyroid, with a small percentage being malignant. The decision for surgery is mainly based on the fine needle aspiration (FNA) cytology report, which is cat...
Citation: BMC Endocrine Disorders 2025 25:119 -
Positive impact of mobile educational platforms on blood glucose control in patients with nephrotic syndrome and steroid-induced diabetes mellitus: a randomized controlled study
Steroid-induced diabetes mellitus (SDM) is a common complication in patients with nephrotic syndrome (NS) undergoing steroid therapy. Effective blood glucose control is critical for improving outcomes in these...
Citation: BMC Endocrine Disorders 2025 25:118 -
Prediction of cardiac autonomic dysfunction using heart rate response to deep breathing test among type 2 diabetes mellitus
Cardiac autonomic neuropathy (CAN) is an underdiagnosed complication of type 2 diabetes mellitus (T2DM) and a predictor of mortality and cardiovascular morbidity. Hence, CAN screening is essential. The objecti...
Citation: BMC Endocrine Disorders 2025 25:117 -
Impact of intraoperative intact PTH monitoring on reoperation rates and surgical success in primary hyperparathyroidism
Primary hyperparathyroidism (PHPT) is caused by excessive parathormone secretion from one or more parathyroid glands. The primary treatment for PHPT is surgery. Due to anatomical variations in the parathyroid ...
Citation: BMC Endocrine Disorders 2025 25:116 -
A new perspective of blood routine test for the prediction and diagnosis of hyperglycemia
The presence of hyperglycemia induces alterations in the blood cell microenvironment. However, further investigations are warranted to comprehend the regulation of physiological parameter changes within the hy...
Citation: BMC Endocrine Disorders 2025 25:115 -
Mediating effect of TyG index on the association between glucose-lipid metabolism-related dietary pattern and T2DM: a propensity score-matched analysis
This study aimed to investigate the association of dietary patterns (DPs) with risk of T2DM, emphasizing the intermediary role of HOMA or TyG indices among a Chinese adult population.
Citation: BMC Endocrine Disorders 2025 25:114 -
Association between glucose time-in-range and the severity of metabolic dysfunction-associated steatotic liver disease in Chinese adults with type 2 diabetes mellitus
This study investigated the correlation between glucose time-in-range (TIR) and hepatic steatosis severity or liver fibrosis risk in Chinese adults with type 2 diabetes mellitus (T2DM) comorbid with metabolic ...
Citation: BMC Endocrine Disorders 2025 25:113 -
SGLT2 inhibitor in a type 2 diabetes mellitus patient coexisted with central diabetes insipidus following hyperosmolar hyperglycemic state
Central diabetes insipidus (CDI) is a rare complication following a hyperglycemic hyperosmolar state (HHS) in patients with type 2 diabetes mellitus (T2DM). The coexistence of T2DM and CDI can lead to diagnost...
Citation: BMC Endocrine Disorders 2025 25:112 -
Hypothyroidism phenotypes, clinical characteristics, and factors associated with nodular thyroid disease in patients with hypothyroidism in Southern Ghana: a 6-year retrospective study
This study aimed to describe the frequency of hypothyroidism phenotypes, clinical characteristics, and factors associated with nodular thyroid among hypothyroid patients at the University of Ghana Hospital in ...
Citation: BMC Endocrine Disorders 2025 25:111 -
The impact of vitamin D supplementation on glycemic control and lipid metabolism in polycystic ovary syndrome: a systematic review of randomized controlled trials
Polycystic ovary syndrome (PCOS) is a prevalent endocrine condition affecting both metabolic and reproductive health in women. The impact of vitamin D on metabolic regulation has attracted growing interest. Th...
Citation: BMC Endocrine Disorders 2025 25:110 -
Recurrent education: A promising strategy for enhancing diabetes management and reducing hypoglycemia in children with type 1 diabetes
This study aimed to assess the impact of recurrent individualized education on the management of hypoglycemia, hypoglycemia awareness, and metabolic control of diabetes in children and adolescents living with ...
Citation: BMC Endocrine Disorders 2025 25:109 -
Association between triglyceride glucose index and depression in polycystic ovary syndrome
The relationship between the triglyceride glucose (TyG) index and the incidence of depression in populations with polycystic ovary syndrome (PCOS) remains unclear. This study aims to investigate the relationsh...
Citation: BMC Endocrine Disorders 2025 25:108 -
Scaffold-free endocrine tissue engineering: role of islet organization and implications in type 1 diabetes
Type 1 diabetes (T1D) is a chronic hyperglycemia disorder emerging from beta-cell (insulin secreting cells of the pancreas) targeted autoimmunity. As the blood glucose levels significantly increase and the ins...
Citation: BMC Endocrine Disorders 2025 25:107 -
Association between thyroid stimulating hormone levels and nonproliferative diabetic retinopathy: a cross-sectional study
The association between thyroid-stimulating hormone (TSH) and type 2 diabetes mellitus (T2DM) is well known. However, whether TSH is related to nonproliferative diabetic retinopathy (NPDR) has not been studied...
Citation: BMC Endocrine Disorders 2025 25:106 -
Association of atherogenic index of plasma with kidney dysfunction in diabetic individuals: findings from two national population-based studies
Extensive evidence suggests that dyslipidemia is associated with endothelial dysfunction, oxidative stress, and inflammation, all of which can contribute to kidney dysfunction. The atherogenic index of plasma ...
Citation: BMC Endocrine Disorders 2025 25:105 -
Atypical presentation of pseudohypoparathyroidism with absence of mutations in the GNAS gene: a case report
This case report aimed to broaden the understanding of pseudohypoparathyroidism (PHP) manifestations when typical mutations in the GNAS gene are absent. The clinical, biochemical, and genetic investigations of a ...
Citation: BMC Endocrine Disorders 2025 25:104 -
Validation of the Persian version of the summary of diabetes self-care activities scale (SDSCA) in pregnant women with gestational diabetes mellitus using a COSMIN methodology
Gestational diabetes mellitus (GDM) is a condition with significant prenatal and postnatal implications. This study aimed to validate the Summary of Diabetes Self-Care Activities (SDSCA) measure in Iranian wom...
Citation: BMC Endocrine Disorders 2025 25:103 -
Dietary iron intake is nonlinearly associated with the risk of diabetic retinopathy in adults with type 2 diabetes
To elucidate the association between dietary iron intake and diabetic retinopathy (DR) in type 2 diabetes (T2D) patients.
Citation: BMC Endocrine Disorders 2025 25:102 -
Sarcopenia in type 2 Diabetes mellitus among Asian populations: prevalence and risk factors based on AWGS- 2019: a systematic review and meta-analysis
Sarcopenia is increasingly recognized as a significant complication in type 2 diabetes mellitus (T2DM), yet its prevalence and risk factors in Asian populations remain incompletely understood using the updated...
Citation: BMC Endocrine Disorders 2025 25:101 -
Elevated high-sensitivity C-reactive protein and dyslipidaemia in type 2 diabetes mellitus: implications for cardiovascular risk prediction in Nigerian patients
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among individuals with type 2 diabetes mellitus (T2DM). Inflammation, marked by elevated high-sensitivity C-reactive protein (hs-CRP) ...
Citation: BMC Endocrine Disorders 2025 25:100 -
The correlation between insulin-like growth factor 1 and left ventricular mass index in obese children
Low levels of Insulin-like Growth Factor 1 (IGF-1) are known risk factors for cardiovascular diseases. Left Ventricular Mass Index (LVMI) serves as an early predictor of adverse cardiovascular events. Obese ch...
Citation: BMC Endocrine Disorders 2025 25:99 -
Clinical value of serum miR-214-3p expression in the diagnosis of type 2 diabetes mellitus and prediction of its chronic complications
The majority of diabetes cases fall into type 2 diabetes mellitus (T2DM), which is prone to chronic complications that have a long-term impact on patients. The aim of this study was to investigate the diagnost...
Citation: BMC Endocrine Disorders 2025 25:98 -
Association of major dietary patterns with the risk of obesity among the population from the South-West of Iran: findings from Hoveyzeh cohort study
Obesity is a multi-factorial metabolic disorder, the development and progression caused by genetic, physiological, metabolic, socio-economic, and lifestyle factors (especially physical activity and diet). Ther...
Citation: BMC Endocrine Disorders 2025 25:97 -
Comparison of triglyceride glucose index and other insulin resistance indexes in children with overweight and obesity
The aim of the study was to determine the correlation between insulin resistance (IR) indexes in children with overweight or obesity.
Citation: BMC Endocrine Disorders 2025 25:96 -
Balancing hormonal symphony: the dynamics of reproduction and pregnancy
The biology and endocrinology of reproduction form a broad and dynamic research field that garners significant attention due to its impact on everyday life. This field involves the study of hormones and neuroe...
Citation: BMC Endocrine Disorders 2025 25:95 -
Evaluation of the clinical pharmacist’s effect on achieving treatment goals in patients with hypothyroidism: a randomized controlled trial
Hypothyroidism (HoT) treatment involves lifelong thyroxine replacement therapy and regular monitoring. The objective of this study was to assess the impact of clinical pharmacist (CP) intervention in managing ...
Citation: BMC Endocrine Disorders 2025 25:94 -
Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study
The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in patients with weight regain after bariatric surgery remains unclear. The objective of this study was to determine the efficacy and safety of ...
Citation: BMC Endocrine Disorders 2025 25:93 -
Metabolic complications and clinical outcomes of non-functioning adrenal incidentalomas: a systematic review and meta-analysis
Increased detection of non-functioning adrenal incidentalomas (NFAI) due to widespread abdominal imaging may underestimate associated metabolic risks. To examine NFAI's impact on metabolic comorbidities and ev...
Citation: BMC Endocrine Disorders 2025 25:92 -
Assessment of self-efficacy, quality of life, and well-being of patients with diabetes mellitus in Alqunfudah, Saudi Arabia
Patients with diabetes mellitus (DM) often experience psychological challenges, such as feelings of loss of control, self-care stress, and fear of complications. This study aimed to assess the prevalence of un...
Citation: BMC Endocrine Disorders 2025 25:91 -
A novel obesity-prevention dietary score is associated with favorable metabolic status and lower blood pressure in obesity
Obesity is a major worldwide health problem and is associated with numerous diseases including diabetes, cardiovascular diseases, and some types of cancers. In the current cross-sectional study, we aimed to ev...
Citation: BMC Endocrine Disorders 2025 25:90 -
Association of dietary glycemic index and glycemic load with pancreatic steatosis: a case control study
Carbohydrate intake, its type and characteristics including glycemic index (GI) and glycemic load (GL) may be associated with the risk of pancreatic steatosis (PS), but there is no conclusive evidence. The aim...
Citation: BMC Endocrine Disorders 2025 25:89 -
Evaluating cloudcare, a population health management system, in persons with type 1 diabetes: an observational study
Innovations in diabetes technology have consistently improved outcomes of persons with type1 diabetes (PWDs). However, the volumes of data that these technologies yield require different workflows to alleviate...
Citation: BMC Endocrine Disorders 2025 25:88 -
Relationship between tobacco smoking and metabolic syndrome: a Mendelian randomization analysis
Numerous epidemiologic observational studies have demonstrated that smokers have an increased risk of developing cardiovascular-related diseases. However, less is known about the causal relationship between to...
Citation: BMC Endocrine Disorders 2025 25:87 -
Development and validation of inpatient mortality prediction models for patients with hyperglycemic crisis using machine learning approaches
Hyperglycemic crisis is one of the most common and severe complications of diabetes mellitus, associated with a high motarlity rate. Emergency admissions due to hyperglycemic crisis remain prevalent and challe...
Citation: BMC Endocrine Disorders 2025 25:86 -
Predictor factors of uncontrolled diabetes
The most significant challenge faced by individuals with diabetes is poor blood sugar control. The objective of this review is to identify the most crucial predictors of poor glycemic control among patients wi...
Citation: BMC Endocrine Disorders 2025 25:84 -
Hyperostosis frontalis interna and association of disease control with frontal bone thickness in acromegaly
Studies investigating hyperostosis frontalis interna (HFI) in acromegaly are limited. We aimed to investigate HFI and the association of disease control with frontal bone thickness (FBT) in acromegaly.
Citation: BMC Endocrine Disorders 2025 25:81
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.8
5-year Journal Impact Factor: 3.1
Source Normalized Impact per Paper (SNIP): 0.914
SCImago Journal Rank (SJR): 0.789
Speed 2024
Submission to first editorial decision (median days): 8
Submission to acceptance (median days): 157
Usage 2024
Downloads: 1,792,683
Altmetric mentions: 766